| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Rudolph E. Tanzi | Q17144968 |
| John Ioannidis | Q6251482 | ||
| Nicole Allen | Q57073925 | ||
| Muin J. Khoury | Q64746271 | ||
| Lars Bertram | Q91179371 | ||
| Fotini K Kavvoura | Q114408184 | ||
| Sachin Bagade | Q114425222 | ||
| P2093 | author name string | Matthew B McQueen | |
| P2860 | cites work | The NMDA/D1 receptor complex as a new target in drug development. | Q36486262 |
| Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration | Q36564570 | ||
| Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis | Q36708789 | ||
| Assessment of cumulative evidence on genetic associations: interim guidelines | Q36952959 | ||
| Uncertainty in heterogeneity estimates in meta-analyses | Q36987539 | ||
| A road map for efficient and reliable human genome epidemiology | Q42680046 | ||
| PBAT: tools for family-based association studies | Q42930203 | ||
| 'Racial' differences in genetic effects for complex diseases | Q44586727 | ||
| Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics | Q45036986 | ||
| Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain | Q47378030 | ||
| Failure to confirm an association between the PLXNA2 gene and schizophrenia in a Japanese population. | Q51906133 | ||
| Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia | Q78035307 | ||
| Why most published research findings are false | Q21092395 | ||
| Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease | Q22337234 | ||
| An exploratory test for an excess of significant findings | Q24273224 | ||
| A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase | Q24324172 | ||
| Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia | Q24532517 | ||
| Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls | Q24550675 | ||
| The case of the misleading funnel plot | Q24676535 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies | Q28190066 | ||
| Schizophrenia: genes at last? | Q28260969 | ||
| Schizophrenia | Q28267772 | ||
| Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database | Q28280965 | ||
| Association of the NRG1 gene and schizophrenia: a meta-analysis | Q28300667 | ||
| A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints | Q29614902 | ||
| Replication validity of genetic association studies | Q29615456 | ||
| Assessing the probability that a positive report is false: an approach for molecular epidemiology studies | Q29616285 | ||
| Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials | Q31170846 | ||
| Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease | Q33276409 | ||
| Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia | Q34004490 | ||
| Spurious precision: procedural validity of diagnostic assessment in psychotic disorders | Q34317506 | ||
| A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? | Q34385362 | ||
| Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia | Q34482858 | ||
| Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia | Q34631349 | ||
| Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia? | Q36258629 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | database | Q8513 |
| meta-analysis | Q815382 | ||
| schizophrenia | Q41112 | ||
| P304 | page(s) | 827-34 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database | |
| P478 | volume | 40 |
| Q37620241 | A Case-Control Study of the Association between Polymorphisms in the Fibrinogen Alpha Chain Gene and Schizophrenia. |
| Q38834709 | A Consensus Network of Gene Regulatory Factors in the Human Frontal Lobe |
| Q92588198 | A Fast and Flexible Framework for Network-Assisted Genomic Association |
| Q48040604 | A Novel Relationship for Schizophrenia, Bipolar, and Major Depressive Disorder. Part 8: a Hint from Chromosome 8 High Density Association Screen |
| Q38914044 | A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density |
| Q26786354 | A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates |
| Q35406944 | A Review of Genetic Association Studies of Obstructive Sleep Apnea: Field Synopsis and Meta-Analysis |
| Q36740391 | A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies |
| Q35477305 | A comparative study of disease genes and drug targets in the human protein interactome |
| Q29417040 | A comprehensive family-based replication study of schizophrenia genes |
| Q34333537 | A comprehensive network and pathway analysis of candidate genes in major depressive disorder |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q27001119 | A conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia |
| Q29417078 | A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype |
| Q28744481 | A hypomethylating variant of MTHFR, 677C>T, blunts the neural response to errors in patients with schizophrenia and healthy individuals |
| Q37715375 | A literature search tool for intelligent extraction of disease-associated genes |
| Q58088683 | A logical relationship for schizophrenia, bipolar, and major depressive disorder. Part 4: Evidence from chromosome 4 high-density association screen |
| Q49220616 | A meta-analysis of data associating DRD4 gene polymorphisms with schizophrenia |
| Q53320826 | A methodology based on molecular interactions and pathways to find candidate genes associated to diseases: its application to schizophrenia and Alzheimer's disease |
| Q42567659 | A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case |
| Q30416311 | A naturally occurring null variant of the NMDA type glutamate receptor NR3B subunit is a risk factor of schizophrenia |
| Q37223784 | A new method for identifying causal genes of schizophrenia and anti-tuberculosis drug-induced hepatotoxicity |
| Q33531348 | A novel microRNA and transcription factor mediated regulatory network in schizophrenia |
| Q33733254 | A novel relationship for schizophrenia, bipolar and major depressive disorder Part 5: a hint from chromosome 5 high density association screen |
| Q33839359 | A population genetic approach to mapping neurological disorder genes using deep resequencing |
| Q34103482 | A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. |
| Q37372778 | A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia |
| Q34266990 | A re-review of the association between the NOTCH4 locus and schizophrenia |
| Q34128269 | A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes |
| Q41393508 | A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples |
| Q38287451 | A systematic appraisal of field synopses in genetic epidemiology: a HuGE review |
| Q48137280 | A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia |
| Q45991476 | A two-stage case-control association study of PADI2 with schizophrenia. |
| Q53072839 | A1166C genetic variation of the angiotensin II type I receptor gene and susceptibility to coronary heart disease: Collaborative of 53 studies with 20,435 cases and 23,674 controls |
| Q35630793 | ADHDgene: a genetic database for attention deficit hyperactivity disorder |
| Q35832061 | AKT/GSK3 signaling pathway and schizophrenia |
| Q39949041 | ALDH2 Glu504Lys Confers Susceptibility to Schizophrenia and Impacts Hippocampal-Prefrontal Functional Connectivity |
| Q46049728 | Abnormalities in extracellular glycine and glutamate levels in the striatum of sandy mice. |
| Q60302510 | Activation of IL-8 and its participation in cancer in schizophrenia patients: new evidence for the autoimmune hypothesis of schizophrenia |
| Q91754596 | Acute stress-induced change in polysialic acid levels mediated by sialidase in mouse brain |
| Q35995272 | Adjuvant chemotherapy for breast cancer in patients with schizophrenia |
| Q34167342 | Advances in the genetics of schizophrenia: will high-risk copy number variants be useful in clinical genetics or diagnostics? |
| Q34283319 | Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap |
| Q29395121 | All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors |
| Q37828827 | Alterations in the expression of neuronal chloride transporters may contribute to schizophrenia |
| Q43645946 | Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder |
| Q35753205 | Altered functional brain network connectivity and glutamate system function in transgenic mice expressing truncated Disrupted-in-Schizophrenia 1 |
| Q34877401 | Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study |
| Q37510100 | Alzheimer's disease genetics current status and future perspectives |
| Q35771085 | An ICA with reference approach in identification of genetic variation and associated brain networks |
| Q44414039 | An association study between the dymeclin gene and schizophrenia in the Japanese population |
| Q37980010 | An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. |
| Q30449225 | An examination of auditory processing and affective prosody in relatives of patients with auditory hallucinations. |
| Q50309747 | An in Silico, Biomarker-Based Method for the Evaluation of Virtual Neuropsychiatric Drug Effects |
| Q37966594 | An integrative functional genomics approach for discovering biomarkers in schizophrenia |
| Q82125863 | An intronic MYLK variant associated with inflammatory lung disease regulates promoter activity of the smooth muscle myosin light chain kinase isoform |
| Q48943149 | Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia |
| Q28740767 | Analysis of genomic variation in non-coding elements using population-scale sequencing data from the 1000 Genomes Project |
| Q35101267 | Analysis of schizophrenia and hepatocellular carcinoma genetic network with corresponding modularity and pathways: novel insights to the immune system |
| Q29619899 | Animal models of neuropsychiatric disorders |
| Q30462828 | Animal models of schizophrenia. |
| Q61449987 | Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects |
| Q40630289 | Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder. |
| Q34419653 | ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype |
| Q35992151 | Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis |
| Q28081379 | Approaching a network connectivity-driven classification of the psychosis continuum: a selective review and suggestions for future research |
| Q61817393 | Assessment of complementarity of WGCNA and NERI results for identification of modules associated to schizophrenia spectrum disorders |
| Q35644834 | Association Study of N-Methyl-D-Aspartate Receptor Subunit 2B (GRIN2B) Polymorphisms and Schizophrenia Symptoms in the Han Chinese Population |
| Q51834165 | Association Study of Tryptophan Hydroxylase-2 Gene in Schizophrenia and Its Clinical Features in Chinese Han Population |
| Q35675412 | Association between Dopamine Receptor D2 (DRD2) Variations rs6277 and rs1800497 and Cognitive Performance According to Risk Type for Psychosis: A Nested Case Control Study in a Finnish Population Sample |
| Q36081661 | Association between PLA2G12A Polymorphisms and Schizophrenia in a Han Chinese Population from Northeast China. |
| Q48231025 | Association between RGS4 variants and psychotic-like experiences in nonclinical individuals. |
| Q36001595 | Association between SNPs and gene expression in multiple regions of the human brain |
| Q36480165 | Association between a genetic variant in the serotonin transporter gene (SLC6A4) and suicidal behavior in patients with schizophrenia |
| Q43278134 | Association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age of onset in schizophrenia |
| Q43877663 | Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population |
| Q48593823 | Association between the NOTCH4 gene rs3131296 polymorphism with schizophrenia risk in the Chinese Zhuang population and Chinese Han population |
| Q60929044 | Association between the gene and schizophrenia: an updated meta-analysis |
| Q37125991 | Association of MTHFR C677T polymorphism with schizophrenia and its effect on episodic memory and gray matter density in patients |
| Q35891516 | Association of PDE4B Polymorphisms with Susceptibility to Schizophrenia: A Meta-Analysis of Case-Control Studies |
| Q21203802 | Association of RGS4 variants with schizotypy and cognitive endophenotypes at the population level |
| Q54338522 | Association of SNPs linked to increased expression of SLC1A1 with schizophrenia. |
| Q90616375 | Association of SOX11 Polymorphisms in distal 3'UTR with Susceptibility for Schizophrenia |
| Q33817717 | Association of dopamine D1 receptor gene polymorphism with schizophrenia: a meta-analysis |
| Q48486533 | Association of serotonin transporter gene (SLC6A4) polymorphisms with schizophrenia susceptibility and symptoms in a Chinese-Han population |
| Q89769130 | Association of the CACNA2D2 gene with schizophrenia in Chinese Han population |
| Q40277287 | Association of the NOTCH4 Gene Polymorphism rs204993 with Schizophrenia in the Chinese Han Population |
| Q33620389 | Association of the PPAR-γ Gene with Altered Glucose Levels and Psychosis Profile in Schizophrenia Patients Exposed to Antipsychotics. |
| Q36500995 | Association of toll-like receptor 3 polymorphism rs3775291 with age-related macular degeneration: a systematic review and meta-analysis |
| Q33778087 | Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses |
| Q59128381 | Astrocytic Regulation of Glutamate Transmission in Schizophrenia |
| Q38601563 | Attempts to replicate genetic associations with schizophrenia in a cohort from north India. |
| Q35631056 | AutismKB: an evidence-based knowledgebase of autism genetics. |
| Q34494739 | Autworks: a cross-disease network biology application for Autism and related disorders |
| Q34206314 | Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models |
| Q34197111 | Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics |
| Q40688564 | BDNF rescues prefrontal dysfunction elicited by pyramidal neuron-specific DTNBP1 deletion in vivo. |
| Q38114256 | BDgene: A Genetic Database for Bipolar Disorder and Its Overlap With Schizophrenia and Major Depressive Disorder |
| Q35505900 | Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors |
| Q39580232 | Beyond dopamine: glutamate as a target for future antipsychotics. |
| Q30473410 | Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia |
| Q37412969 | Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome |
| Q24623385 | Biological invasions: a field synopsis, systematic review, and database of the literature |
| Q34919885 | Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls |
| Q33993209 | Biomarkers in development of psychotropic drugs |
| Q47563572 | Brain structure in women at risk of postpartum psychosis: an MRI study |
| Q36378009 | CIDeR: multifactorial interaction networks in human diseases |
| Q37416864 | COMT influences on prefrontal and striatal blood oxygenation level-dependent responses during working memory among individuals with schizophrenia, their siblings, and healthy controls |
| Q59329370 | COMT, 5-HTR2A, and SLC6A4 mRNA Expressions in First-Episode Antipsychotic-Naïve Schizophrenia and Association With Treatment Outcomes |
| Q37284307 | COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation |
| Q37710652 | CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells |
| Q36181600 | CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in neurodevelopment |
| Q91867564 | Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type? |
| Q37983548 | Can genetics inform the management of cognitive deficits in schizophrenia? |
| Q37320809 | Candidate genes involved in neural plasticity and the risk for attention-deficit hyperactivity disorder: a meta-analysis of 8 common variants. |
| Q43928105 | Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. |
| Q33615547 | Catechol-o-methyltransferase valine(158)methionine genotype and resting regional cerebral blood flow in medication-free patients with schizophrenia |
| Q35875021 | Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene. |
| Q47109740 | Characteristics of allelic gene expression in human brain cells from single-cell RNA-seq data analysis |
| Q48147266 | Childhood neglect predicts disorganization in schizophrenia through grey matter decrease in dorsolateral prefrontal cortex. |
| Q86815194 | Chromosomal Distribution of Schizophrenia Susceptibility Loci |
| Q28308288 | Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer |
| Q91855609 | Chronic methamphetamine interacts with BDNF Val66Met to remodel psychosis pathways in the mesocorticolimbic proteome |
| Q90310996 | Clinical and Genetic Factors Associated with Resistance to Treatment in Patients with Schizophrenia: A Case-Control Study |
| Q36380279 | Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era |
| Q45237932 | Clinical response to antipsychotic drug treatment: Association study of polymorphisms in six candidate genes |
| Q35085481 | Clinically detectable copy number variations in a Canadian catchment population of schizophrenia |
| Q35352888 | Clock genes control cortical critical period timing |
| Q34856932 | Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6p. |
| Q30476447 | Cognitive control deficits in schizophrenia: mechanisms and meaning |
| Q51818773 | Common SNPs in CSF2RB are associated with major depression and schizophrenia in the Chinese Han population |
| Q35369852 | Common variants in the MKL1 gene confer risk of schizophrenia. |
| Q41312111 | Common variants of HTR1A and SLC6A4 confer the increasing risk of Schizophrenia susceptibility: A population-based association and epistasis analysis |
| Q44039446 | Common variants of the PINK1 and PARL genes do not confer genetic susceptibility to schizophrenia in Han Chinese. |
| Q33762506 | Common variants on Xq28 conferring risk of schizophrenia in Han Chinese |
| Q33895253 | Comparative Linkage Meta-Analysis Reveals Regionally-Distinct, Disparate Genetic Architectures: Application to Bipolar Disorder and Schizophrenia |
| Q40181690 | Comparative genomic evidence for the involvement of schizophrenia risk genes in antipsychotic effects. |
| Q35613651 | Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia |
| Q36481732 | Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma |
| Q50356287 | Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes |
| Q29417106 | Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database |
| Q43868487 | Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain. |
| Q44996725 | Controversial Effects of D-Amino Acid Oxidase Activator (DAOA)/G72 on D-Amino Acid Oxidase (DAO) Activity in Human Neuronal, Astrocyte and Kidney Cell Lines: The N-methyl D-aspartate (NMDA) Receptor Hypofunction Point of View |
| Q36189837 | Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. |
| Q55020959 | Convergent roles of de novo mutations and common variants in schizophrenia in tissue-specific and spatiotemporal co-expression network. |
| Q84146518 | Converging evidence implicates the dopamine D3 receptor gene in vulnerability to schizophrenia |
| Q30439224 | Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders |
| Q41913384 | Credible genetic associations? |
| Q34409301 | Cross-cultural standardization of the South Texas Assessment of Neurocognition in India |
| Q40437176 | Currently recognized genes for schizophrenia: High-resolution chromosome ideogram representation. |
| Q40814411 | Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer |
| Q38188664 | D-Serine in neurobiology: CNS neurotransmission and neuromodulation. |
| Q36297843 | D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians |
| Q39394930 | D-amino acid oxidase is expressed in the ventral tegmental area and modulates cortical dopamine |
| Q37722074 | DISC1 and SLC12A2 interaction affects human hippocampal function and connectivity |
| Q34170101 | DISC1 conditioned GWAS for psychosis proneness in a large Finnish birth cohort |
| Q34088110 | DNA methylation changes in the postmortem dorsolateral prefrontal cortex of patients with schizophrenia |
| Q39038285 | DNA methylation in psychosis: insights into etiology and treatment |
| Q53239856 | DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population |
| Q86016943 | DRD2 haplotype associated with negative symptoms and sustained attention deficits in Han Chinese with schizophrenia in Taiwan |
| Q34508840 | DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia |
| Q35959200 | Deletions in chromosome 6p22.3-p24.3, including ATXN1, are associated with developmental delay and autism spectrum disorders |
| Q41967395 | Detection of susceptibility genes as modifiers due to subgroup differences in complex disease |
| Q47427328 | Developing the "next generation" of genetic association databases for complex diseases |
| Q35989824 | Development of a Melting Curve-Based Allele-Specific PCR of Apolipoprotein E (APOE) Genotyping Method for Genomic DNA, Guthrie Blood Spot, and Whole Blood |
| Q89736173 | Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond |
| Q36591363 | Developmental regulation of expression of schizophrenia susceptibility genes in the primate hippocampal formation. |
| Q30386868 | Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function |
| Q35028294 | Disrupted-in-Schizophrenia-1 SNPs and Susceptibility to Schizophrenia: Evidence from Malaysia |
| Q33882290 | Dissociable genetic contributions to error processing: a multimodal neuroimaging study |
| Q36945440 | Diverse types of genetic variation converge on functional gene networks involved in schizophrenia |
| Q38120741 | Does the dopamine hypothesis explain schizophrenia? |
| Q35746544 | Dopamine in socioecological and evolutionary perspectives: implications for psychiatric disorders |
| Q36557505 | Dopaminergic foundations of schizotypy as measured by the German version of the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE)—a suitable endophenotype of schizophrenia |
| Q50762367 | Dopaminergic gene polymorphisms affect long-term forgetting in old age: further support for the magnification hypothesis |
| Q30368373 | Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia. |
| Q28575296 | Dysbindin is a potent inducer of RhoA-SRF-mediated cardiomyocyte hypertrophy |
| Q34603149 | Dysbindin-1 genotype effects on emotional working memory |
| Q37357632 | Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression |
| Q34488600 | Dysbindin-associated proteome in the p2 synaptosome fraction of mouse brain |
| Q93047581 | Dysregulated Glial Differentiation in Schizophrenia May Be Relieved by Suppression of SMAD4- and REST-Dependent Signaling |
| Q38781633 | Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related Phenotypes. |
| Q46320813 | EFHC1 variants in juvenile myoclonic epilepsy: reanalysis according to NHGRI and ACMG guidelines for assigning disease causality |
| Q36809759 | Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis. |
| Q26823735 | Effects of antipsychotics on dentate gyrus stem cell proliferation and survival in animal models: a critical update |
| Q48414204 | Effects of neuregulin-1 genetic variation and depression symptom severity on longitudinal patterns of psychotic symptoms in primary care attendees |
| Q38440780 | Electrophysiological endophenotypes in rodent models of schizophrenia and psychosis |
| Q35738958 | Elevated DISC1 transcript levels in PBMCs during acute psychosis in patients with schizophrenia |
| Q44706927 | Enhanced prepulse inhibition and low sensitivity to a dopamine agonist in HESR1 knockout mice |
| Q41774176 | Enhancement of gamma activity after selective activation of dopamine D4 receptors in freely moving rats and in a neurodevelopmental model of schizophrenia |
| Q36793393 | EnigmaVis: online interactive visualization of genome-wide association studies of the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium |
| Q48276910 | Enriched expression of genes associated with autism spectrum disorders in human inhibitory neurons |
| Q42910419 | Enzyme activity of the PIP4K2A gene product polymorphism that is implicated in schizophrenia |
| Q38367862 | Epigenetic considerations of the APOE gene. [corrected]. |
| Q24652697 | Epigenetic mediation of environmental influences in major psychotic disorders |
| Q36258528 | Epigenetic profiling of human brain differential DNA methylation networks in schizophrenia |
| Q37711120 | Epigenetics and biomarkers in the staging of neuropsychiatric disorders |
| Q28082318 | Evaluating historical candidate genes for schizophrenia |
| Q41657246 | Evaluating the dopamine hypothesis of schizophrenia in a large-scale genome-wide association study |
| Q30428422 | Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia |
| Q35712593 | Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian randomization analysis. |
| Q38073527 | Evidence of a dimensional relationship between schizotypy and schizophrenia: A systematic review |
| Q43284473 | Evidence of association of serotonin transporter gene polymorphisms with schizophrenia in a South Indian population |
| Q37307172 | Evidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder |
| Q39291081 | Evidence that interactive effects of COMT and MTHFR moderate psychotic response to environmental stress. |
| Q48229488 | Evolutionary and genetic features of drug targets. |
| Q28657468 | Evolutionary conservation in genes underlying human psychiatric disorders |
| Q30997126 | Exome Sequence Data From Multigenerational Families Implicate AMPA Receptor Trafficking in Neurocognitive Impairment and Schizophrenia Risk |
| Q33505860 | Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation. |
| Q83823284 | Exploring functional polymorphisms in the dopamine receptor D2 gene using prolactin concentration in healthy subjects |
| Q50659985 | Exploring the indirect effects of catechol-O-methyltransferase (COMT) genotype on psychotic experiences through cognitive function and anxiety disorders in a large birth cohort of children. |
| Q34026208 | Expression Profiling of Autism Candidate Genes during Human Brain Development Implicates Central Immune Signaling Pathways |
| Q42107408 | Expression of D-Amino Acid Oxidase (DAO/DAAO) and D-Amino Acid Oxidase Activator (DAOA/G72) during Development and Aging in the Human Post-mortem Brain. |
| Q37412229 | Field-wide meta-analyses of observational associations can map selective availability of risk factors and the impact of model specifications |
| Q26744755 | From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia |
| Q34632695 | From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment |
| Q37660158 | From nature versus nurture, via nature and nurture, to gene x environment interaction in mental disorders |
| Q36043312 | Functional genomics indicate that schizophrenia may be an adult vascular-ischemic disorder |
| Q54432303 | Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia--a case-control study. |
| Q37092462 | Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. |
| Q35744819 | Further evidence for a male-selective genetic association of synapse-associated protein 97 (SAP97) gene with schizophrenia |
| Q47159972 | Further evidence for the genetic association between CACNA1I and schizophrenia |
| Q42943044 | Further evidence that methylenetetrahydrofolate reductase A1298C polymorphism is a risk factor for schizophrenia |
| Q38749650 | G72 primate-specific gene: a still enigmatic element in psychiatric disorders |
| Q30479407 | GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders |
| Q46346737 | GRIN2B predicts attention problems among disadvantaged children. |
| Q41512733 | GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant schizophrenia: A genetic association study in Brazilian patients. |
| Q36356850 | GWAB: a web server for the network-based boosting of human genome-wide association data. |
| Q33390788 | Gene Prospector: an evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases |
| Q30447546 | Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia |
| Q38508234 | Gene- and evidence-based candidate gene selection for schizophrenia and gene feature analysis |
| Q38636465 | Genetic Associations of Interleukin-related Genes with Graves' Ophthalmopathy: a Systematic Review and Meta-analysis |
| Q36071808 | Genetic Factors Modulating the Response to Stimulant Drugs in Humans |
| Q33439272 | Genetic and environmental pathways to complex diseases |
| Q37724204 | Genetic association between the dopamine D1-receptor gene and paranoid schizophrenia in a northern Han Chinese population |
| Q38058276 | Genetic association studies in pre-eclampsia: systematic meta-analyses and field synopsis |
| Q35791049 | Genetic associations between neuregulin-1 SNPs and neurocognitive function in multigenerational, multiplex schizophrenia families |
| Q37962479 | Genetic epidemiology with a capital E, ten years after |
| Q38110180 | Genetic models of schizophrenia and related psychotic disorders: progress and pitfalls across the methodological "minefield". |
| Q33630685 | Genetic modifiers of abnormal organelle biogenesis in a Drosophila model of BLOC-1 deficiency. |
| Q42950120 | Genetic polymorphisms in dopamine- and serotonin-related genes and treatment responses to risperidone and perospirone |
| Q24289176 | Genetic research in schizophrenia: new tools and future perspectives |
| Q35671932 | Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women |
| Q38189197 | Genetic variants and risk of cervical cancer: epidemiological evidence, meta-analysis and research review |
| Q35043093 | Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence |
| Q39597945 | Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence |
| Q36621035 | Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia |
| Q50508007 | Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes |
| Q33533750 | Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance |
| Q37846725 | Genetics in psychiatry: are the promises met? |
| Q37777200 | Genetics in psychiatry: common variant association studies |
| Q35237268 | Genetics in schizophrenia: where are we and what next? |
| Q37884607 | Genetics of Schizophrenia: New Findings and Challenges |
| Q22252693 | Genetics of psychosis; insights from views across the genome |
| Q41873795 | Genetics of schizophrenia: What do we know? |
| Q38283524 | Genetics studies indicate that neural induction and early neuronal maturation are disturbed in autism |
| Q35109411 | Genome-wide analysis shows increased frequency of copy number variation deletions in Dutch schizophrenia patients |
| Q24289213 | Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases |
| Q24273247 | Genome-wide association studies: a primer |
| Q28943275 | Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2 |
| Q37156043 | Genome-wide association study of smoking initiation and current smoking |
| Q35881801 | Genome-wide expression profiling of schizophrenia using a large combined cohort |
| Q36188465 | Genome-wide linkage scan of antisocial behavior, depression, and impulsive substance use in the UCSF family alcoholism study. |
| Q30914210 | Genome-wide scan for signatures of human population differentiation and their relationship with natural selection, functional pathways and diseases |
| Q34606096 | Genomewide association studies: history, rationale, and prospects for psychiatric disorders |
| Q33382735 | Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum |
| Q35960747 | Genomic sister-disorders of neurodevelopment: an evolutionary approach |
| Q34898538 | Genotype-phenotype databases: challenges and solutions for the post-genomic era. |
| Q38790623 | Geographical and ethnic distribution of MTHFR gene polymorphisms and their associations with diseases among Chinese population |
| Q30362301 | GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia |
| Q37607775 | Glutamate receptor mutations in psychiatric and neurodevelopmental disorders |
| Q30387014 | Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. |
| Q24655660 | HGVbaseG2P: a central genetic association database |
| Q33507732 | Haplotype frequencies at the DRD2 locus in populations of the East European Plain |
| Q28275290 | Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia |
| Q30991988 | Hierarchical Classes Analysis (HICLAS): A novel data reduction method to examine associations between biallelic SNPs and perceptual organization phenotypes in schizophrenia |
| Q51804953 | Hippocampal serotonin depletion facilitates the enhancement of prepulse inhibition by risperidone: Possible role of 5-HT2C receptors in the dorsal hippocampus |
| Q50069193 | How Good Were Candidate Gene Guesses in Schizophrenia Genetics? |
| Q38152423 | How might ZNF804A variants influence risk for schizophrenia and bipolar disorder? A literature review, synthesis, and bioinformatic analysis |
| Q35213673 | How much do we know about schizophrenia and how well do we know it? Evidence from the Schizophrenia Library |
| Q38011402 | Human genetics of schizophrenia |
| Q37944127 | Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder? |
| Q34303110 | Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association results |
| Q30839452 | Identification of ANKK1 rs1800497 variant in schizophrenia: new data and meta-analysis |
| Q43616392 | Identification of blood biomarkers for psychosis using convergent functional genomics. |
| Q35005483 | Identification of the mRNA expression status of the dopamine D2 receptor and dopamine transporter in peripheral blood lymphocytes of schizophrenia patients |
| Q34407170 | Identifying novel interventional strategies for psychiatric disorders: integrating genomics, 'enviromics' and gene-environment interactions in valid preclinical models. |
| Q36960113 | Immature dentate gyrus: an endophenotype of neuropsychiatric disorders. |
| Q26830533 | Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits |
| Q38106974 | Impact of structural aberrancy of polysialic acid and its synthetic enzyme ST8SIA2 in schizophrenia |
| Q45065209 | Impact of the Reelin signaling cascade (ligands-receptors-adaptor complex) on cognition in schizophrenia |
| Q87439143 | Impaired impulse control is associated with a 5-HT2A receptor polymorphism in schizophrenia |
| Q30884931 | Incorporation of personal single nucleotide polymorphism (SNP) data into a national level electronic health record for disease risk assessment, part 1: an overview of requirements. |
| Q59667688 | Increased exonic de novo mutation rate in individuals with schizophrenia |
| Q48237523 | Increased expression of dysbindin-1A leads to a selective deficit in NMDA receptor signaling in the hippocampus |
| Q38138169 | Inflammatory cytokine network in schizophrenia |
| Q33575236 | Inhibition of NMDARs in the Nucleus Reticularis of the Thalamus Produces Delta Frequency Bursting |
| Q47961367 | Integrating Imaging Genomic Data in the Quest for Biomarkers for Schizophrenia Disease |
| Q37219339 | Integrating precision medicine in the study and clinical treatment of a severely mentally ill person |
| Q37572176 | Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses |
| Q47160977 | Integrative Analysis to Identify Common Genetic Markers of Metabolic Syndrome, Dementia, and Diabetes. |
| Q24609513 | Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis |
| Q48025093 | Investigating association of four gene regions (GABRB3, MAOB, PAH, and SLC6A4) with five symptoms in schizophrenia |
| Q39861509 | Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia |
| Q33942309 | Is Ankyrin a genetic risk factor for psychiatric phenotypes? |
| Q24289007 | Knowledge Integration in Cancer: Current Landscape and Future Prospects |
| Q35715112 | LPA signaling initiates schizophrenia-like brain and behavioral changes in a mouse model of prenatal brain hemorrhage |
| Q53159308 | Linkage and association on 8p21.2-p21.1 in schizophrenia. |
| Q30762130 | Loss of Nicastrin from Oligodendrocytes Results in Hypomyelination and Schizophrenia with Compulsive Behavior. |
| Q36566216 | Loss of dysbindin-1 in mice impairs reward-based operant learning by increasing impulsive and compulsive behavior |
| Q45772698 | Lung cancer risk and genetic variants in East Asians: a meta-analysis |
| Q35106857 | MCPerm: a Monte Carlo permutation method for accurately correcting the multiple testing in a meta-analysis of genetic association studies |
| Q28727310 | MK4MDD: A Multi-Level Knowledge Base and Analysis Platform for Major Depressive Disorder |
| Q36970899 | MTHFR 677C --> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val --> Met. |
| Q34498919 | MTHFR 677C>T effects on anterior cingulate structure and function during response monitoring in schizophrenia: a preliminary study |
| Q30575713 | Medial prefrontal cortex: genes linked to bipolar disorder and schizophrenia have altered expression in the highly social maternal phenotype |
| Q90602676 | Mental disorders and an acidic glycan-from the perspective of polysialic acid (PSA/polySia) and the synthesizing enzyme, ST8SIA2 |
| Q34048609 | Meta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophrenia. |
| Q89503430 | Meta-analysis and field synopsis of genetic variants associated with the risk and severity of acute pancreatitis |
| Q31039070 | Meta-analysis and genome-wide interpretation of genetic susceptibility to drug addiction |
| Q24273398 | Meta-analysis in genome-wide association studies |
| Q35986264 | Meta-analysis indicates that common variants at the DISC1 locus are not associated with schizophrenia |
| Q34775946 | Meta-analysis indicates that the European GWAS-identified risk SNP rs1344706 within ZNF804A is not associated with schizophrenia in Han Chinese population |
| Q55423202 | Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium. |
| Q34999939 | Meta-analysis of gene coexpression networks in the post-mortem prefrontal cortex of patients with schizophrenia and unaffected controls |
| Q41951188 | Meta-analysis of genetic variation in DTNBP1 and general cognitive ability |
| Q28741124 | Meta-analysis of paternal age and schizophrenia risk in male versus female offspring |
| Q35906525 | Meta-analysis of sex differences in gene expression in schizophrenia |
| Q28544818 | Method designed to respect molecular heterogeneity can profoundly correct present data interpretations for genome-wide expression analysis |
| Q57832728 | Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and age of onset in schizophrenia: A combined analysis of independent samples |
| Q37083847 | Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age at onset of schizophrenia: no consistent evidence for an association in the Nordic population |
| Q47160929 | Methylenetetrahydrofolate reductase A1298C genetic variant & risk of schizophrenia: A meta-analysis. |
| Q24630375 | MicroRNA dysregulation in psychiatric disease |
| Q33955198 | MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia |
| Q38673966 | Mining databases for protein aggregation: a review |
| Q33797632 | Model-based optimization approaches for precision medicine: A case study in presynaptic dopamine overactivity. |
| Q37055287 | Modeling cognitive endophenotypes of schizophrenia in mice |
| Q34165986 | Modeling motivational deficits in mouse models of schizophrenia: behavior analysis as a guide for neuroscience |
| Q30476813 | Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects |
| Q38162886 | Modernizing the systematic review process to inform comparative effectiveness: tools and methods |
| Q38126653 | Modulation of NMDA receptor function as a treatment for schizophrenia |
| Q38023890 | Molecular Genetics of the Psychosis Phenotype |
| Q34336202 | Molecular profiles of pyramidal neurons in the superior temporal cortex in schizophrenia |
| Q37839960 | Molecules, Signaling, and Schizophrenia |
| Q35877150 | Monoamine transporters: vulnerable and vital doorkeepers |
| Q37224256 | Multi-regression analysis revealed a relationship between l-serine and methionine, a component of one-carbon metabolism, in the normal control but not in the schizophrenia |
| Q90214599 | Multi-scale analysis of schizophrenia risk genes, brain structure, and clinical symptoms reveals integrative clues for subtyping schizophrenia patients |
| Q36035361 | Multifaceted genomic risk for brain function in schizophrenia |
| Q36640241 | Multiple Regulatory Variants Modulate Expression of 5-Hydroxytryptamine 2A Receptors in Human Cortex |
| Q34348224 | Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction |
| Q30745171 | Multivariate Genetic Correlates of the Auditory Paired Stimuli-Based P2 Event-Related Potential in the Psychosis Dimension From the BSNIP Study |
| Q28257683 | Multivariate analysis of anxiety disorders yields further evidence of linkage to chromosomes 4q21 and 7p in panic disorder families |
| Q24632939 | Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia |
| Q34098648 | Mutant mouse models: phenotypic relationships to domains of psychopathology and pathobiology in schizophrenia |
| Q27315950 | Mutation of Semaphorin-6A disrupts limbic and cortical connectivity and models neurodevelopmental psychopathology |
| Q30474021 | N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? |
| Q36718684 | NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia |
| Q36245009 | NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia |
| Q35133013 | NPAS3 variants in schizophrenia: a neuroimaging study |
| Q35237190 | Nature and nurture in neuropsychiatric genetics: where do we stand? |
| Q34335485 | Network-Assisted Investigation of Combined Causal Signals from Genome-Wide Association Studies in Schizophrenia |
| Q30981632 | Network-Based Analysis of Schizophrenia Genome-Wide Association Data to Detect the Joint Functional Association Signals |
| Q36162707 | Network-assisted Causal Gene Detection in Genome-wide Association Studies: An Improved Module Search Algorithm |
| Q37022792 | Neural markers of errors as endophenotypes in neuropsychiatric disorders |
| Q29036263 | Neural mechanisms underlying stress resilience in Ahi1 knockout mice: relevance to neuropsychiatric disorders |
| Q30458926 | Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy |
| Q30481233 | Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background |
| Q48149496 | Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system |
| Q34423863 | Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia |
| Q33856171 | New Genetic Findings in Schizophrenia: Is there Still Room for the Dopamine Hypothesis of Schizophrenia? |
| Q37374232 | New findings from genetic association studies of schizophrenia |
| Q46660680 | No Evidence That Schizophrenia Candidate Genes Are More Associated With Schizophrenia Than Noncandidate Genes. |
| Q33809001 | No association of dysbindin with symptom factors of schizophrenia in an Irish case-control sample |
| Q34178853 | No paradox, no progress: inverse cancer comorbidity in people with other complex diseases |
| Q49390228 | Non-coding RNA dysregulation in the amygdala region of schizophrenia patients contributes to the pathogenesis of the disease |
| Q41950823 | Olanzapine Reversed Brain Gene Expression Changes Induced by Phencyclidine Treatment in Non-Human Primates |
| Q37258674 | Omega-3 fatty acid deficiency disrupts endocytosis, neuritogenesis, and mitochondrial protein pathways in the mouse hippocampus |
| Q40841854 | PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome |
| Q36367450 | Paradox of schizophrenia genetics: is a paradigm shift occurring? |
| Q47589125 | Paternal and maternal age as risk factors for schizophrenia: a case-control study |
| Q64986488 | Pathway-specific protein domains are predictive for human diseases. |
| Q33707734 | Pathway-wide association study identifies five shared pathways associated with schizophrenia in three ancestral distinct populations |
| Q50303296 | Penetrance for copy number variants associated with schizophrenia |
| Q34082704 | Perinatal folate-related exposures and risk of psychotic symptoms in the ALSPAC birth cohort |
| Q27012892 | Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research |
| Q40773725 | Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice |
| Q30884325 | Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionary viewpoint |
| Q34726454 | Personalized medicine in psychiatry: problems and promises |
| Q34970259 | PharmGKB summary: dopamine receptor D2 |
| Q47998134 | Pharmacodynamic genetic variants related to antipsychotic adverse reactions in healthy volunteers |
| Q56806254 | Pilot Study on Schizophrenia in Sardinia |
| Q51021515 | Polymorphisms associated with normal memory variation also affect memory impairment in schizophrenia |
| Q35932619 | Polymorphisms in MicroRNA Genes And Genes Involving in NMDAR Signaling and Schizophrenia: A Case-Control Study in Chinese Han Population |
| Q44426449 | Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targets |
| Q35540025 | Polymorphisms of methylenetetrahydrofolate reductase are not a risk factor for Kawasaki disease in the Korean population |
| Q46318735 | Post-GWAS in Psychiatric Genetics: A Developmental Perspective on the "Other" Next Steps |
| Q43706186 | Postnatal maternal deprivation and pubertal stress have additive effects on dopamine D2 receptor and CaMKII beta expression in the striatum |
| Q47370065 | Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines |
| Q90761159 | Precision and personalized assessment, diagnosis and treatment in psychiatry |
| Q47318364 | Prediction Analysis for Transition to Schizophrenia in Individuals at Clinical High Risk for Psychosis: The Relationship of DAO, DAOA, and NRG1 Variants with Negative Symptoms and Cognitive Deficits |
| Q37563065 | Prefrontal cognitive systems in schizophrenia: towards human genetic brain mechanisms |
| Q41867856 | Prefronto-striatal physiology is associated with schizotypy and is modulated by a functional variant of DRD2 |
| Q33842223 | Prioritization of Epilepsy Associated Candidate Genes by Convergent Analysis |
| Q30954335 | Profound human/mouse differences in alpha-dystrobrevin isoforms: a novel syntrophin-binding site and promoter missing in mouse and rat. |
| Q44122430 | Protein–protein interaction analysis reveals common molecular processes/pathways that contribute to risk of schizophrenia |
| Q39586408 | Psychosis Incident Cohort Outcome Study (PICOS). A multisite study of clinical, social and biological characteristics, patterns of care and predictors of outcome in first-episode psychosis. Background, methodology and overview of the patient sample |
| Q28576146 | Quaking Regulates Hnrnpa1 Expression through Its 3′ UTR in Oligodendrocyte Precursor Cells |
| Q35856391 | Quantitative proteomic and genetic analyses of the schizophrenia susceptibility factor dysbindin identify novel roles of the biogenesis of lysosome-related organelles complex 1. |
| Q37765631 | REVIEW: Genome-wide findings in schizophrenia and the role of gene-environment interplay. |
| Q35383040 | Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia |
| Q35844049 | Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. |
| Q89174583 | Reagent Validation to Facilitate Experimental Reproducibility |
| Q38260258 | Recent genetic findings in schizophrenia and their therapeutic relevance |
| Q92694047 | Reduced cortical thickness related to single nucleotide polymorphisms in the major histocompatibility complex region in antipsychotic-naive schizophrenia |
| Q30524246 | Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine. |
| Q86669431 | Reducing peripheral serotonin turns up the heat in brown fat |
| Q37628145 | Relation between variants in the neurotrophin receptor gene, NTRK3, and white matter integrity in healthy young adults |
| Q99552118 | Relationship between Single Nucleotide Polymorphisms of GRHL3 and Schizophrenia Susceptibility: A Preliminary Case-Control Study and Bioinformatics Analysis |
| Q36087025 | Relationship of a variant in the NTRK1 gene to white matter microstructure in young adults |
| Q41735608 | Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies |
| Q57317030 | Risikogene der Schizophrenie und ihre neuralen Effekte |
| Q47559782 | Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses |
| Q36755212 | Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics |
| Q28486157 | Risk factors for violence in psychosis: systematic review and meta-regression analysis of 110 studies |
| Q46162576 | Role of COMT in ADHD: a Systematic Meta-Analysis |
| Q47874458 | Role of DISC1 interacting proteins in schizophrenia risk from genome-wide analysis of missense SNPs. |
| Q36137795 | Role of N-Methyl-D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia |
| Q47792372 | Rs1076560, a functional variant of the dopamine D2 receptor gene, confers risk of schizophrenia in Han Chinese |
| Q39705556 | SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution |
| Q39566363 | SZDB: A Database for Schizophrenia Genetic Research |
| Q33819217 | SZGR: a comprehensive schizophrenia gene resource |
| Q34830762 | Schizophrenia Genetics: Where Next? |
| Q30416883 | Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models |
| Q38122060 | Schizophrenia and dopamine receptors |
| Q21284097 | Schizophrenia and vitamin D related genes could have been subject to latitude-driven adaptation |
| Q37862242 | Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment |
| Q37483078 | Schizophrenia genetics: new insights from new approaches |
| Q37064920 | Schizophrenia genomics and proteomics: are we any closer to biomarker discovery? |
| Q34623618 | Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes |
| Q59117302 | Schizophrenia: The Epidemiological Horizon |
| Q37792088 | Schizophrenia: Treatment Targets Beyond Monoamine Systems |
| Q34023115 | Schizophrenia: an integrated sociodevelopmental-cognitive model |
| Q37461052 | Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers |
| Q43258034 | Schizophrenia: the "BLOC" may be in the endosomes |
| Q36132584 | Screening of reproduction-related single-nucleotide variations from MeDIP-seq data in sheep |
| Q27024141 | Search for missing schizophrenia genes will require a new developmental neurogenomic perspective |
| Q37559492 | Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future |
| Q34470145 | Searching joint association signals in CATIE schizophrenia genome-wide association studies through a refined integrative network approach |
| Q34313985 | Segment-wise genome-wide association analysis identifies a candidate region associated with schizophrenia in three independent samples |
| Q30473381 | Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study |
| Q30475351 | Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers |
| Q30495175 | Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B. |
| Q93042005 | Sex-differential DNA methylation and associated regulation networks in human brain implicated in the sex-biased risks of psychiatric disorders |
| Q37767805 | Signaling pathways in schizophrenia: emerging targets and therapeutic strategies |
| Q35542783 | Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives |
| Q64937673 | Species-Specific Changes in a Primate Transcription Factor Network Provide Insights into the Molecular Evolution of the Primate Prefrontal Cortex. |
| Q42156149 | Structural and Functional Impairments of Polysialic Acid by a Mutated Polysialyltransferase Found in Schizophrenia |
| Q46117859 | Survey of schizophrenia and bipolar disorder candidate genes using chromatin immunoprecipitation and tiled microarrays (ChIP-chip). |
| Q33842202 | Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location |
| Q35838464 | SynaptomeDB: an ontology-based knowledgebase for synaptic genes |
| Q38602946 | Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas |
| Q27021946 | Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer |
| Q24289342 | Systematic meta-analyses and field synopsis of genetic association studies of violence and aggression |
| Q34323019 | Systematic prioritization and integrative analysis of copy number variations in schizophrenia reveal key schizophrenia susceptibility genes |
| Q33414801 | Systematic reviews of genetic association studies. Human Genome Epidemiology Network |
| Q92700646 | Systems Chemical Genetics-Based Drug Discovery: Prioritizing Agents Targeting Multiple/Reliable Disease-Associated Genes as Drug Candidates |
| Q38069972 | Systems biology, bioinformatics, and biomarkers in neuropsychiatry |
| Q26750901 | Systems psychopharmacology: A network approach to developing novel therapies |
| Q45824282 | T102C polymorphism of serotonin 2A type receptor gene confers susceptibility to (early onset) schizophrenia in Han Chinese: An association study and meta‐analysis |
| Q36456196 | Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study |
| Q34279073 | The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions |
| Q30251841 | The Association of SNAP25 Gene Polymorphisms in Attention Deficit/Hyperactivity Disorder: a Systematic Review and Meta-Analysis. |
| Q33559787 | The COPD genetic association compendium: a comprehensive online database of COPD genetic associations |
| Q34653284 | The DAO gene is associated with schizophrenia and interacts with other genes in the Taiwan Han Chinese population |
| Q83479287 | The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neurons |
| Q33833630 | The Impact of Multifunctional Genes on "Guilt by Association" Analysis |
| Q34455707 | The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond |
| Q55250881 | The Response Patterns of Arbuscular Mycorrhizal and Ectomycorrhizal Symbionts Under Elevated CO2: A Meta-Analysis. |
| Q38863895 | The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia |
| Q34140126 | The Role of Rodent Models in The Discovery of New Treatments for Schizophrenia: Updating Our Strategy |
| Q26752281 | The SNP rs1625579 in miR-137 gene and risk of schizophrenia in Chinese population: A meta-analysis |
| Q30466238 | The association of schizophrenia risk D-amino acid oxidase polymorphisms with sensorimotor gating, working memory and personality in healthy males. |
| Q33743615 | The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients |
| Q34275010 | The dice are rolling for schizophrenia genetics |
| Q22242827 | The dopamine hypothesis of schizophrenia: version III--the final common pathway |
| Q24338919 | The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth |
| Q33809026 | The dystrobrevin-binding protein 1 gene: features and networks |
| Q33695382 | The effect of COMT Val158Met and DRD2 C957T polymorphisms on executive function and the impact of early life stress |
| Q38006632 | The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants |
| Q55361790 | The evolution of a series of behavioral traits is associated with autism-risk genes in cavefish. |
| Q36484372 | The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1. |
| Q35415495 | The genetic validation of heterogeneity in schizophrenia |
| Q92453423 | The genetics of bipolar disorder |
| Q35186661 | The genetics of cognitive impairment in schizophrenia: a phenomic perspective |
| Q37784829 | The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline |
| Q30362017 | The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia. |
| Q30404784 | The moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine |
| Q33611796 | The neurobiology of D-amino acid oxidase and its involvement in schizophrenia. |
| Q26859392 | The neuroimmunology of schizophrenia |
| Q37791205 | The origins and evolution of genetic disease risk in modern humans |
| Q57159888 | The role of acid-sensitive ion channels in panic disorder: a systematic review of animal studies and meta-analysis of human studies |
| Q28748800 | The role of genetics in the etiology of schizophrenia |
| Q38004234 | The role of parasites and pathogens in influencing generalised anxiety and predation-related fear in the mammalian central nervous system. |
| Q37714973 | The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research |
| Q92913340 | The schizophrenia genetics knowledgebase: a comprehensive update of findings from candidate gene studies |
| Q24293250 | The schizophrenia susceptibility factor dysbindin and its associated complex sort cargoes from cell bodies to the synapse |
| Q33716681 | The serotonin transporter gene and risk for alcohol dependence: a meta-analytic review. |
| Q37519468 | The tryptophan hydroxylase 1 (TPH1) gene, schizophrenia susceptibility, and suicidal behavior: a multi-centre case-control study and meta-analysis |
| Q33624412 | Theranostic Biomarkers for Schizophrenia |
| Q28385221 | Tilting at quixotic trait loci (QTL): an evolutionary perspective on genetic causation |
| Q37870394 | Timing as a window on cognition in schizophrenia |
| Q24289349 | Toward modernizing the systematic review pipeline in genetics: efficient updating via data mining |
| Q24634447 | Toxoplasma gondii and Other Risk Factors for Schizophrenia: An Update |
| Q28709645 | Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders |
| Q38422738 | Transcranial direct current stimulation and neuroplasticity genes: implications for psychiatric disorders |
| Q34913157 | Transcriptome alterations of mitochondrial and coagulation function in schizophrenia by cortical sequencing analysis |
| Q35918319 | Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia. |
| Q33940022 | Transcriptome-wide discovery of microRNA binding sites in human brain. |
| Q36948917 | Transient and selective overexpression of D2 receptors in the striatum causes persistent deficits in conditional associative learning |
| Q35739457 | Translating Glutamate: From Pathophysiology to Treatment |
| Q38699013 | Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies. |
| Q46728777 | Translational Genetic Modelling of 3D Craniofacial Dysmorphology: Elaborating the Facial Phenotype of Neurodevelopmental Disorders Through the "Prism" of Schizophrenia |
| Q47397598 | Translational bioinformatics in mental health: open access data sources and computational biomarker discovery |
| Q36034031 | Triangulating meta-analyses: the example of the serotonin transporter gene, stressful life events and major depression |
| Q42291040 | Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia |
| Q33793694 | Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder |
| Q34023768 | Understanding the Complex Etiologies of Developmental Disorders: Behavioral and Molecular Genetic Approaches |
| Q57709293 | Variabilidad en el gen COMT y modificación del riesgo de esquizofrenia conferido por consumo de cannabis |
| Q60534534 | Variability of the COMT gene and modification of the risk of schizophrenia conferred by cannabis consumption |
| Q47102005 | Verbal memory improvement in first-episode psychosis APOE-ε4 carriers: a pleiotropic effect? |
| Q38213305 | Vitamin supplementation in the treatment of schizophrenia |
| Q35680065 | Vulnerability of synapses in the frontal cortex of mice developmentally exposed to an insecticide: Potential contribution to neuropsychiatric disease |
| Q89181998 | Weighted mining of massive collections of [Formula: see text]-values by convex optimization |
| Q36637021 | What does a mouse tell us about neuregulin 1-cannabis interactions? |
| Q37159625 | What we know: findings that every theory of schizophrenia should explain. |
| Q44800774 | ZNF804A and schizophrenia susceptibility in Asian populations. |
| Q34182670 | ZNF804a Regulates Expression of the Schizophrenia-Associated Genes PRSS16, COMT, PDE4B, and DRD2 |
| Q34027329 | d-Serine: The right or wrong isoform? |
| Q36554272 | d-amino acid oxidase knockout (Dao(-/-) ) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption |
| Q38031285 | d-serine and schizophrenia: an update |
| Q37645440 | miR-137: a new player in schizophrenia |
| Q34405175 | miRNA Regulation of Gene Expression: A Predictive Bioinformatics Analysis in the Postnatally Developing Monkey Hippocampus |
Search more.